Pfizer, the giant drug company, was on the verge of finishing a move that would allow it to dodge some $35 billion in taxes, known as an "inversion" ... but the U.S. Treasury issued a new rule which caused Pfizer to cancel its planned inversion merger.
After Fair Share, in coalition with groups across the country, called for new Treasury action, they responded this week by issuing the new rule. Fair Share members sent in thousands of comments in support, and Americans for Tax Fairness, a coalition of groups working to make the tax code more fair, together reached more than 120,000 comments.